J Rhinol.  2003 Nov;10(1, 2):37-41.

Effect of Roxithromycin and Intranasal Fluticasone Spray in Reducing Symptoms of Chronic Sinusitis, Polyp Size and IL-4 in Allergic Patients

• Kim BG
• Lee DM
• Jo JH
• Jung DG
• Kang JM
• Kim SW

Abstract

Nasal polyp is an intractable condition usually associated with chronic hyperplastic sinusitis with allergic rhinitis. IL-4 is known to contribute to the inflammatory reaction by enhancing binding of inflammatory cells in the nasal polyp. The objectives of this study were to evaluate the effect of roxithromycin (300 mg daily) and intranasal fluticasone spray (200 microgram daily ) in reducing symptoms of chronic sinusitis and polyp size and to compare pre - and post-treatment secretion of IL-4. Twenty-four patients with chronic sinusitis with nasal polyp and allergic rhinitis were selected and allocated into 3 groups ; roxythromycin, fluticasone propionate and combined use group. Statistically significant decrease in symptoms was observed in both the roxythromycin and fluticasone propionate groups. Significant improvement of rhinorrhea and postnasal drip was observed in the combined use group. The polyp size decreased significantly in all three groups. IL-4 secretion decreased significantly in the combined use group after treatment. Long term medication of roxithromycin and intranasal fluticasone spray were effective in reducing symptoms and polyp size in chronic sinusitis with allergic rhinitis. They were also effective in reducing IL-4.

Keyword

Nasal polyp; Chronic sinusitis ; IL-4; Roxithromycin; Fluticasone propionate

MeSH Terms

Diethylpropion
Humans
Interleukin-4*
Nasal Polyps
Polyps*
Rhinitis
Roxithromycin*
Sinusitis*
Fluticasone
Diethylpropion
Interleukin-4
Roxithromycin